Glaxo to put cancer drugs into final trials
1st Dec 2005, 06:21 GMT
LONDON (Reuters) - GlaxoSmithKline GSK.L will put four new cancer drugs into final-stage clinical trials next year, as it sets its sights on a leading position in the drug industry's fastest-growing market.
Glaxo to put cancer drugs into final trials related news:
- Glaxo sees 4 cancer drugs in final trials in 2006 (Reuters) — Yahoo! News: Health News
- Glaxo to put 4 new cancer drugs into final trials — Reuters: Health
- Glaxo to put 4 new cancer drugs into final trials (Reuters) — Yahoo! News: Health News
- Glaxo sees 4 cancer drugs in final trials in 2006 — RedOrbit News - Health
- Glaxo Bullish on Cancer Drugs — Red Herring
- Glaxo Highlights Tykerb Cancer Drug — WSJ.com: US Business
- GSK in drive for new cancer drugs — Business
- Too Many Cancer Patients Continue to Smoke (HealthDay) — Yahoo! News: Health News
- GSK presents positive cancer drug data — FT.com / Home UK
- Glaxo looks to become cancer drug leader — CNNmoney.com - International News
Latest news from Reuters: Business:
- O2 ups revenue forecasts as additions zoom
- MoD, fraud office probe BAE over Tanzania deal
- AMEC rejects private equity approach
- BT says to cut wholesale broadband pricing
- AMEC spurns bid approach from private equity team
- Factory gate inflation weakest in 2-1/2 years
- FTSE 100 sheds early gains
- House price inflation reaches 18-mth high
- Cable co NTL shares down on expectation of ITV bid
- FTSE hit by falling metals, takeover talk supports